English
Segment disclosures
Company overviewPerspective Therapeutics, Inc.
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
2 dimension combinations 20 retained observations 6 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Operating Segments · Brachytherapy Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=catx:BrachytherapySegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 1909000 | USD | 20231114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 5239000 | USD | 20231114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1500000 | USD | 20230811 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 3330000 | USD | 20230811 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1830000 | USD | 20230515 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 1717000 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 7132000 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 2505000 | USD | 20230811 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 5415000 | USD | 20230811 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 2910000 | USD | 20230515 | Open filing evidence |
Operating Segments · Drug Operations Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=catx:DrugOperationsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-07-01 – 2023-09-30 | 276000 | USD | 20231114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 1097000 | USD | 20231114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 588000 | USD | 20230811 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 821000 | USD | 20230811 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 233000 | USD | 20230515 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 0 | USD | 20231114 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20231114 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20230811 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20230811 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20230515 | Open filing evidence |